Approved Hospital Formulary
Add Formweb to your mobile device
Search results for:
adalimumab
adalimumab
Brand names: Humira
| Form | Strength |
|---|---|
| KIT, SUBCUTANEOUS | 40 mg/0.8 mL |
VIEW MORE GI Drugs, Miscellaneous, Skin and Mucous Membrane Agents, Miscellaneous, Immunomodulatory Agents, Disease-Modifying Antirheumatic Drugs
CLASS
CLASS
569200, 849200, 922000, 923600
Last updated: Jan. 9, 2024
- RCRA: Disposal
- RCRA: Management of Pharmaceutical Waste Policy
- Black Box Warning: Infection risk; malignancy in children and adolescents
- Restricted Restricted Medication
This medication is Inpatient Non-formulary and Restricted to Outpatient Use. Inpatient use requires approval by a physician department leader (i.e. Medical Director or Chair, or hospital CMO) collaborating with a pharmacy leader.
See HERE for more information and workflow.
See HERE for additional pharmacy workflow details.